Contact Information
Company Information
Company
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Professional Summary
Bethany Dudek serves as Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) operates in the research sector with approximately 370.0 employees. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) generates annual revenue of 166000.0.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
We have verified contacts for 2 executives at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
-
•
Our database includes 201,464 c suite-level executives.
Technologies
DNS Made Easy
Outlook
Adobe Marketing Cloud
Salesforce
Adobe Media Optimizer
Vimeo
Linkedin Marketing Solutions
Mobile Friendly
Google Tag Manager
Akamai RUM
Cedexis Radar
Google Font API
reCAPTCHA
New Relic
WordPress.org
Gravity Forms
Nginx
Varnish
Android
IoT
Data Analytics
Remote
Basis
AI
Keywords
biotechnology
medical dermatology
drug development
inflammation
immunology
clinical trials
topical drugs
bioscience
commercialization
plaque psoriasis
atopic dermatitis
eczema
biotechnology: pharmaceutical preparations
health care
biotechnology research
innovative treatments
immune-mediated skin diseases
chronic inflammatory diseases
topical therapies
pde4 inhibitors
zoryve cream
zoryve foam
seborrheic dermatitis
scalp psoriasis
chronic hand eczema
vitiligo
alopecia areata
fda approval
patient access
safety & efficacy
treatment options
methotrexate
biologics
topical corticosteroids
skin barrier repair
patient assistance programs
clinical research
medical professionals
telemedicine solutions
patient education
personalized dermatology
patient care
dermatology expertise
new drug applications
long-term disease management
dermatology innovation
therapeutic outcomes
unmet medical needs
disease management
medical affairs
biotherapeutics
scientific publications
investigator-initiated trials
medical insights
adverse effects management
drug formulation
patient support programs
strategic collaborations
immune-mediated diseases
topical treatments
psoriasis
jak inhibitors
innovative therapies
patient-centric
fda-approved products
dermatological conditions
strategic partnerships
market positioning
patient demographics
psychographic segmentation
behavioral analysis
immuno-dermatology
product pipeline
zoryve
roflumilast
collaborations
commercial-stage
healthcare professionals
dermatology market
therapeutic innovation
patient quality of life
scientific research
market access
financial growth
community engagement
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like Bethany Dudek in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
Bethany Dudek's Position in the MessageCEO Database
- •Bethany Dudek is 1 of 2 verified executive contacts we track at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •14 verified contacts work at research companies in the 370.0 employee range (same size as Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.
Frequently Asked Questions
How do I reach Bethany Dudek directly?
Bethany Dudek's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Bethany Dudek work for?
Bethany Dudek is Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a company in the research sector with 370.0 employees.
Can I pitch or sell to Bethany Dudek?
As Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), Bethany Dudek is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Bethany Dudek directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Bethany Dudek in?
Bethany Dudek works in the research industry as Chief Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). MessageCEO provides verified contact information for executives across all major industries.
Is Bethany Dudek's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Bethany Dudek's profile is kept up-to-date with the latest available information.
Last updated: November 6, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans